quantitative epityper® massarray (agena bioscience)
Structured Review

Quantitative Epityper® Massarray, supplied by agena bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/quantitative epityper® massarray/product/agena bioscience
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer"
Article Title: BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer
Journal: Cancers
doi: 10.3390/cancers12040828
Figure Legend Snippet: Correlation between methylation-specific PCR and EpiTYPER® MassARRAY® methylation evaluation ( n = 153). Black columns indicate discordant cases ( n = 4, methylation percentage assessed by MassARRAY® = 9.5, 6, 4, and 4), using a positivity cut-off of 10%.
Techniques Used: Methylation
Figure Legend Snippet: Univariate clinicopathological correlations with BRCA1 promoter methylation using MS-PCR.
Techniques Used: Methylation, Expressing
Figure Legend Snippet: Distribution of CpG sites analyzed in the promoter region of the BRCA1 gene. ( A ) The BRCA1–NBR2 locus: the position of the first exons of the BRCA1 is indicated by shaded boxes. The first exon of NBR2 gene is indicated by a black box. ( B ) Position of CpG sites analyzed Cytosine on CpG sites tested by MS-PCR are underlined. Cytosine on CpG sites tested by MassARRAY® EpiTYPER® assay are in bold. The positive strand of the BRCA1 gene is shown based on GenBank accession number U37574. The transcription start site of the BRCA1 exon 1A is marked by an arrow. Exon 1A sequence is in capital, and both 5’upstream sequence and intron 1 sequence are in lower case characters.
Techniques Used: MassARRAY EpiTYPER assay, Sequencing

